We’ve been spending some time on the National Pain Report recently reporting on spinal cord stimulation. In particular, we are following a patient, Phil Meade a 70-year old Utah man suffering from sciatica and other back issues as he decides whether to have an SCS implanted. Here is our introductory story and here’s something from this week as he nears a decision to have the implant.
By the way, we are always interested in how your experience was with SCS or if you are considering it, what kinds of questions you have.
As far as the technology itself is concerned, it has been a dynamic couple of weeks, as companies have been making announcements about new products and applications in the field, which continues to expand.
Three different manufacturers have made announcements about new technology that treats pain differently than traditional spinal cord stimulation systems. The SCS market is $1.3 billion and competition is heating up.
Most importantly, the hope is with competition comes better pain therapy.